Comparison of the metabolic and economic consequences of long-term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost-effectiveness analysis (Q43025405)
Jump to navigation
Jump to search
scientific article published on 10 June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of the metabolic and economic consequences of long-term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost-effectiveness analysis |
scientific article published on 10 June 2010 |
Statements
1 reference
Comparison of the metabolic and economic consequences of long-term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost-effectiveness analysis (English)
1 reference
Roger S McIntyre
1 reference
Lael Cragin
1 reference
Sonja Sorensen
1 reference
Huseyin Naci
1 reference
Tim Baker
1 reference
Jean-Pascal Roussy
1 reference
10 June 2010
1 reference
1 reference
16
1 reference
4
1 reference
744-755
1 reference
1 reference
Identifiers
1 reference
1 reference